94 related articles for article (PubMed ID: 22207979)
21. [Determination of free type and complex type prostate-specific antigen (PSA): differences in immunorecognition by Delfia PSA, ACS-PSA and Eiken PA kits].
Sumi S; Umeda H; Koga F; Yano M; Imai T; Hosoya Y; Honda M; Maeda S; Suzuki T; Yoshida K; Negishi T
Hinyokika Kiyo; 1996 Apr; 42(4):279-84. PubMed ID: 8693960
[TBL] [Abstract][Full Text] [Related]
22. [Clinical evaluation of a new kit (IMX PA Dainapack) for detection of serum prostate specific antigen].
Machida T; Ohishi Y; Wada T; Akimoto S; Shimazaki J; Oda H; Yokoyama M; Tsukada T; Nakayama T; Akiyama A
Hinyokika Kiyo; 1993 Oct; 39(10):977-84. PubMed ID: 7505519
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Dec; 34(12):2143-8. PubMed ID: 2467543
[TBL] [Abstract][Full Text] [Related]
24. [Value of prostate-specific antigen measurements with newly developed enzyme immunoassay (MARKIT-M PA)].
Arai Y; Onishi H; Oishi K; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1992 Oct; 38(10):1129-34. PubMed ID: 1282772
[TBL] [Abstract][Full Text] [Related]
25. New 'calibrator' should improve prostate cancer testing.
Oncology (Williston Park); 1995 Nov; 9(11):1222. PubMed ID: 8703692
[No Abstract] [Full Text] [Related]
26. [Serum level of prostatic specific antigen in 100 patients with prostatic biopsy].
Arista-Nasr J; Figueroa-Granados V; Caballero-Mendoza E; Schneider O; López-Carrasco G; Kanan-Falcón M
Rev Invest Clin; 1998; 50(6):487-90. PubMed ID: 10070220
[TBL] [Abstract][Full Text] [Related]
27. [Value of serum PSA and PAP measurement with newly developed latex turbidimetric immunoassay].
Akino H; Tsuka H; Okada K; Tsuchiya Y; Matsubara M; Arimura K
Hinyokika Kiyo; 1995 Jun; 41(6):439-45. PubMed ID: 7544063
[TBL] [Abstract][Full Text] [Related]
28. Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010.
;
Int J Urol; 2010 Oct; 17(10):830-8. PubMed ID: 20825509
[TBL] [Abstract][Full Text] [Related]
29. PSA velocity and prostate cancer detection: the absence of evidence is not the evidence of absence.
Perrin P
Eur Urol; 2006 Mar; 49(3):418-9. PubMed ID: 16459016
[No Abstract] [Full Text] [Related]
30. [Clinical significance of prostate specific antigen and gamma-seminoprotein ratio for diagnosing prostate cancer].
Akino H; Suzuki Y; Okada K
Nihon Rinsho; 1998 Aug; 56(8):2003-5. PubMed ID: 9750496
[TBL] [Abstract][Full Text] [Related]
31. [Gamma-seminoprotein (gamma-Sm)].
Miyahara S
Nihon Rinsho; 2005 Aug; 63 Suppl 8():698-701. PubMed ID: 16149615
[No Abstract] [Full Text] [Related]
32. [The incidence of the variability of the free PSA/total PSA ratio on the early diagnosis of prostate cancer].
de La Taille A; Houlgatte A; Houdelette P; Berlizot P; Fournier R; Ricordel I
Prog Urol; 1997 Jun; 7(3):455-63. PubMed ID: 9273075
[TBL] [Abstract][Full Text] [Related]
33. Molecular forms of serum prostate-specific antigen: the clinical usefulness of percent free PSA to discriminate prostate cancer from BPH.
Abrahamsson PA; Kuriyama M
Hinyokika Kiyo; 1998 Apr; 44(4):223-32. PubMed ID: 9617617
[TBL] [Abstract][Full Text] [Related]
34. Prostate-specific antigen: current status.
Lukes M; Urban M; Záleský M; Zachoval R; Herácek J; Zdárský E
Folia Biol (Praha); 2001; 47(2):41-9. PubMed ID: 11321246
[TBL] [Abstract][Full Text] [Related]
35. [Prostatic specific antigen: role and significance in urologic practice].
Manolović D; Pejcić T; Milović N
Srp Arh Celok Lek; 1994; 122(5-6):171-3. PubMed ID: 17977420
[TBL] [Abstract][Full Text] [Related]
36. [Differential diagnostic value of prostate-specific antigen in prostatic hyperplasia].
Maksimov VA; Kamalov AA; Karpov VK; Riaboĭ AV; Prokhorov AV
Urologiia; 2001; (2):37-40. PubMed ID: 11490716
[TBL] [Abstract][Full Text] [Related]
37. Prostate-specific antigen as a tumor marker in prostate cancer.
Kuriyama M
Int J Urol; 1994 Jun; 1(2):99-113. PubMed ID: 7543013
[No Abstract] [Full Text] [Related]
38. [Prostate-specific antigen as a tumor marker of prostate carcinoma].
Wymenga LF; Mensink HJ
Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1733-8. PubMed ID: 10494319
[TBL] [Abstract][Full Text] [Related]
39. Prostate specific antigen. Experimental and clinical observations.
Huber PR; Schnell Y; Hering F; Rutishauser G
Scand J Urol Nephrol Suppl; 1987; 104():33-9. PubMed ID: 2449722
[TBL] [Abstract][Full Text] [Related]
40. Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.
Jansen FH; van Schaik RH; Kurstjens J; Horninger W; Klocker H; Bektic J; Wildhagen MF; Roobol MJ; Bangma CH; Bartsch G
Eur Urol; 2010 Jun; 57(6):921-7. PubMed ID: 20189711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]